Anuh Pharma Limited (NSE:ANUHPHR)

Anuh Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	98.48	80.6	195.57	72.02	19.27	37.96
Short-Term Investments	877.85	59.52	15.02	12.37	8.1	-
Trading Asset Securities	-	389.08	523.56	538.17	503.4	214.69
Cash & Short-Term Investments	976.33	529.19	734.15	622.56	530.77	252.65
Cash Growth	645.52%	-27.92%	17.92%	17.29%	110.08%	91.21%
Accounts Receivable	1,898	2,386	2,159	1,899	1,712	1,357
Other Receivables	-	87.72	97.33	61.96	39.14	5.25
Receivables	1,908	2,482	2,261	1,968	1,756	1,370
Inventory	1,725	1,478	744.81	754	726.36	799.23
Prepaid Expenses	-	16.8	17.72	5.88	5.72	4.79
Restricted Cash	-	-	-	-	30.5	-
Other Current Assets	54.6	7.3	3.54	35.29	26.61	159.98
Total Current Assets	4,664	4,513	3,762	3,385	3,076	2,587
Property, Plant & Equipment	529.47	560.92	583.66	492.42	526.76	613.41
Long-Term Investments	250.65	395.83	619.55	517.14	396.84	212.13
Other Intangible Assets	4.36	5.29	1.21	1.58	1.31	1.83
Long-Term Deferred Tax Assets	25.58	38.62	20.8	4.22	7.68	-
Other Long-Term Assets	62.67	58.97	77.76	53.99	41.09	57.51
Total Assets	5,537	5,574	5,066	4,457	4,050	3,472

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,466	1,877	1,568	1,405	1,528	1,216
Accrued Expenses	-	6.96	7.08	6.16	4.74	3.34
Short-Term Debt	194.76	-	104.98	20.13	-	31.11
Current Portion of Leases	-	0.58	3.3	2.91	0.67	2.06
Current Income Taxes Payable	12.3	23.16	5.48	-	-	-
Other Current Liabilities	246.16	122.75	95.85	92.72	80.29	56.81
Total Current Liabilities	1,919	2,030	1,785	1,527	1,613	1,309
Long-Term Leases	-	-	0.58	3.88	8.39	9.07
Pension & Post-Retirement Benefits	-	12.21	12.92	11.05	9.91	9.72
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.48
Other Long-Term Liabilities	18.46	9.21	7.39	2.75	5.93	5.69
Total Liabilities	1,937	2,051	1,806	1,545	1,638	1,334

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	501.12	501.12	250.56	250.56	250.56	250.56
Retained Earnings	-	3,018	3,009	2,660	2,160	1,886
Comprehensive Income & Other	3,098	2.99	1.14	1.31	1.69	1.3
Shareholders' Equity	3,599	3,522	3,260	2,912	2,412	2,138
Total Liabilities & Equity	5,537	5,574	5,066	4,457	4,050	3,472

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	194.76	0.58	108.86	26.93	9.07	42.24
Net Cash (Debt)	781.57	528.61	625.28	595.63	521.7	210.41
Net Cash Growth	507.35%	-15.46%	4.98%	14.17%	147.94%	-
Net Cash Per Share	7.80	5.27	12.48	5.94	5.21	2.10
Filing Date Shares Outstanding	100.12	100.22	100.22	100.22	100.22	100.22
Total Common Shares Outstanding	100.12	100.22	100.22	100.22	100.22	100.22
Working Capital	2,745	2,483	1,977	1,858	1,463	1,278
Book Value Per Share	35.95	35.14	32.53	29.06	24.07	21.33
Tangible Book Value	3,595	3,517	3,259	2,911	2,411	2,136
Tangible Book Value Per Share	35.91	35.09	32.52	29.04	24.06	21.31
Land	-	15.59	15.59	15.59	113.07	113.07
Buildings	-	148.57	146.73	146.73	146.73	146.73
Machinery	-	1,032	941.3	767.32	723.6	713.5
Construction In Progress	-	-	2.72	4.54	-	1

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error